Study results published in today's issue of Blood Advances

precision oncology in hematological cancers

This study was designed to evaluate Notable’s drug sensitivity screening platform in patients with myelodysplastic syndrome (MDS) and related myeloid neoplasms.

Format

PNG

Source

Notable Labs

Downloads